Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Histone modification is key in treating chronic inflammatory skin diseases.

Vitamin D is crucial for skin health and managing skin diseases.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

New drug delivery methods can make natural compounds more effective and stable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

People with Mucopolysaccharidoses often have skin problems like thick skin and extra hair, and recognizing these can help diagnose and treat the condition early.

Anthrax bacteria can infect and destroy hair follicles in mice, but the immune system eventually clears the infection.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

The circadian clock influences the behavior and regeneration of stem cells in the body.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.